Artificial Intelligence
Global Colonoscopy Devices Market to Reach $2 Billion by 2027
New York, July 16, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Colonoscopy Devices Industry” – https://www.reportlinker.com/p05896566/?utm_source=GNW
5 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 3.8% over the analysis period 2020-2027. Visualization Systems, one of the segments analyzed in the report, is projected to record a 3.9% CAGR and reach US$938.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Colonoscopes segment is readjusted to a revised 4.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $446.6 Million, While China is Forecast to Grow at 6.5% CAGR
The Colonoscopy Devices market in the U.S. is estimated at US$446.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$172.8 Million by the year 2027 trailing a CAGR of 6.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR.
Other Product Types Segment to Record 3.5% CAGR
In the global Other Product Types segment, USA, Canada, Japan, China and Europe will drive the 3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$268.4 Million in the year 2020 will reach a projected size of US$330.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$264.7 Million by the year 2027, while Latin America will expand at a 4.6% CAGR through the analysis period.
Select Competitors (Total 17 Featured)
- FUJIFILM Holdings America Corporation
- GI View Ltd
- HUGER Medical Instrument Co.,Ltd
- KARL STORZ SE & Co. KG
- MECAN MEDICAL EQUIPMENT CO LTD
- Medtronic Plc
- Olympus America
- PENTAX Medical
- Pro Scope Systems
- Sonoscape Medical Corp.
- STERIS Plc
Read the full report: https://www.reportlinker.com/p05896566/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Drop in Colorectal Cancer Screenings due to COVID-19 Crisis
Impacts the Colonoscopy Devices Market
Colonoscopy: The Journey from Conventional Devices to Robotic
Platform
Existing CRC Diagnostic Approaches
Conventional Colonoscopy
CT-Scan/Virtual Colonoscopy
Wireless Capsule Endoscopy (WCE)
Increasing Focus on Magnetically-Driven Robotic Platform
Colonoscopy Devices Market Prospects and Outlook
Regional Market Perspective
Leading Players
WORLD BRANDS
RECENT MARKET ACTIVITY
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of Colorectal Cancer Spurs Market Growth
Global Cancer Incidence by Region: 2018
Global Cancer Incidence by Type: 2018
Common Cause of Cancer Deaths Worldwide – Number of Deaths due
to Select Types of Cancer for 2018
Colorectal Cancer Mortality and Screening Trends in the US
Percentage Breakdown of New Cases for Colon and Rectum Cancers
by Gender (2019)
Growing Preference for Minimally Invasive Surgeries Drives
Demand for Colonoscopy systems
Aging Population Drives Demand for Colonoscopy Devices
Global Population of 65+ Individuals (In 000s) by Region for
the Years 2015, 2020 & 2025
Colorectal Cancer Burden Gradually Shifts from Older
Individuals to Younger Population
Increasing Healthcare Expenditure to Foster Growth
World Healthcare Expenditure (In US$ Trillion) for the Years
2016 & 2018
Per Capita Healthcare Expenditure (in $) by Select Countries
for 2018
Recent Technological Advancements and Launches Drive Market Growth
Prepless, Ingestible Imaging Capsule to Screen Colorectal Cancer
Artificial Intelligence to Hold Instrumental Role in Timely
Identification of Colorectal Cancer during Colonoscopy
Invendo Medical Develops Single-use Invendoscope SC200 with OEM
Peristaltic Pumps
SMART Medical Systems Introduces G-EYE® 760R Colonoscope in Europe
Fujifilm Europe Launches CAD EYE Function for Real-Time
Identification of Colonic Polyp during Colonoscopy
Motus GI Introduces Pure-Vu GEN2 Colon Cleansing System for
Colonoscopy Bowel Preparation
Demand Increases for Colon Capsules
World Capsule Endoscopy Market by Product Segment (%): 2019E
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Colonoscopy
Devices by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Colonoscopy Devices by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Colonoscopy Devices by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Visualization
Systems by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Visualization Systems by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Visualization Systems by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Colonoscopes by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 8: World Historic Review for Colonoscopes by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 9: World 15-Year Perspective for Colonoscopes by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for Other Product
Types by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 11: World Historic Review for Other Product Types by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Other Product Types by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Hospitals by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 14: World Historic Review for Hospitals by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 15: World 15-Year Perspective for Hospitals by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 16: World Current & Future Analysis for Diagnostic
Centers by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Diagnostic Centers by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Diagnostic Centers by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 19: World Current & Future Analysis for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 20: World Historic Review for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for Other End-Uses by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
Rising Incidence of Colorectal Cancer Cases Spurs Growth in
Colonoscopy Devices
Estimated Number of New Cancer Cases and Deaths in the US (2019)
Table 22: USA Current & Future Analysis for Colonoscopy Devices
by Product Type – Visualization Systems, Colonoscopes and Other
Product Types – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 23: USA Historic Review for Colonoscopy Devices by
Product Type – Visualization Systems, Colonoscopes and Other
Product Types Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 24: USA 15-Year Perspective for Colonoscopy Devices by
Product Type – Percentage Breakdown of Value Sales for
Visualization Systems, Colonoscopes and Other Product Types for
the Years 2012, 2020 & 2027
Table 25: USA Current & Future Analysis for Colonoscopy Devices
by End-Use – Hospitals, Diagnostic Centers and Other End-Uses –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 26: USA Historic Review for Colonoscopy Devices by
End-Use – Hospitals, Diagnostic Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 27: USA 15-Year Perspective for Colonoscopy Devices by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers and Other End-Uses for the Years 2012, 2020 &
2027
CANADA
Number of New Cancer Cases in Canada: 2019
Table 28: Canada Current & Future Analysis for Colonoscopy
Devices by Product Type – Visualization Systems, Colonoscopes
and Other Product Types – Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 29: Canada Historic Review for Colonoscopy Devices by
Product Type – Visualization Systems, Colonoscopes and Other
Product Types Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 30: Canada 15-Year Perspective for Colonoscopy Devices by
Product Type – Percentage Breakdown of Value Sales for
Visualization Systems, Colonoscopes and Other Product Types for
the Years 2012, 2020 & 2027
Table 31: Canada Current & Future Analysis for Colonoscopy
Devices by End-Use – Hospitals, Diagnostic Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 32: Canada Historic Review for Colonoscopy Devices by
End-Use – Hospitals, Diagnostic Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 33: Canada 15-Year Perspective for Colonoscopy Devices by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers and Other End-Uses for the Years 2012, 2020 &
2027
JAPAN
Graying Population Spurs Growth Prospects
Japanese Elderly (65+ Years) Population: 2000-2022
Table 34: Japanese Current & Future Analysis for Colonoscopy
Devices by Product Type – Visualization Systems, Colonoscopes
and Other Product Types – Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027
Table 35: Japanese Historic Review for Colonoscopy Devices by
Product Type – Visualization Systems, Colonoscopes and Other
Product Types Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019
Table 36: Japanese 15-Year Perspective for Colonoscopy Devices
by Product Type – Percentage Breakdown of Value Sales for
Visualization Systems, Colonoscopes and Other Product Types for
the Years 2012, 2020 & 2027
Table 37: Japanese Current & Future Analysis for Colonoscopy
Devices by End-Use – Hospitals, Diagnostic Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027
Table 38: Japanese Historic Review for Colonoscopy Devices by
End-Use – Hospitals, Diagnostic Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019
Table 39: Japanese 15-Year Perspective for Colonoscopy Devices
by End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers and Other End-Uses for the Years 2012, 2020 &
2027
Table 34: Japan Current & Future Analysis for Colonoscopy
Devices by Product Type – Visualization Systems, Colonoscopes
and Other Product Types – Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 35: Japan Historic Review for Colonoscopy Devices by
Product Type – Visualization Systems, Colonoscopes and Other
Product Types Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 36: Japan 15-Year Perspective for Colonoscopy Devices by
Product Type – Percentage Breakdown of Value Sales for
Visualization Systems, Colonoscopes and Other Product Types for
the Years 2012, 2020 & 2027
Table 37: Japan Current & Future Analysis for Colonoscopy
Devices by End-Use – Hospitals, Diagnostic Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 38: Japan Historic Review for Colonoscopy Devices by
End-Use – Hospitals, Diagnostic Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 39: Japan 15-Year Perspective for Colonoscopy Devices by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers and Other End-Uses for the Years 2012, 2020 &
2027
CHINA
Rising Incidence of Cancer to Drive the Colonoscopy Devices Market
Number of New Cancer Cases Diagnosed (in Thousands) in China: 2019
Table 40: China Current & Future Analysis for Colonoscopy
Devices by Product Type – Visualization Systems, Colonoscopes
and Other Product Types – Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 41: China Historic Review for Colonoscopy Devices by
Product Type – Visualization Systems, Colonoscopes and Other
Product Types Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 42: China 15-Year Perspective for Colonoscopy Devices by
Product Type – Percentage Breakdown of Value Sales for
Visualization Systems, Colonoscopes and Other Product Types for
the Years 2012, 2020 & 2027
Table 43: China Current & Future Analysis for Colonoscopy
Devices by End-Use – Hospitals, Diagnostic Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 44: China Historic Review for Colonoscopy Devices by
End-Use – Hospitals, Diagnostic Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 45: China 15-Year Perspective for Colonoscopy Devices by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers and Other End-Uses for the Years 2012, 2020 &
2027
EUROPE
Rising Colon Cancer Incidence Augur Well for European
Colonoscopy Devices Market
Cancer Incidence in Europe: Number of New Cancer Cases
(in Thousands) by Site for 2018
Number of New Cancer Cases Diagnosed (in Thousands) in the UK:
2018
Table 46: Europe Current & Future Analysis for Colonoscopy
Devices by Geographic Region – France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 47: Europe Historic Review for Colonoscopy Devices by
Geographic Region – France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 48: Europe 15-Year Perspective for Colonoscopy Devices by
Geographic Region – Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027
Table 49: Europe Current & Future Analysis for Colonoscopy
Devices by Product Type – Visualization Systems, Colonoscopes
and Other Product Types – Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 50: Europe Historic Review for Colonoscopy Devices by
Product Type – Visualization Systems, Colonoscopes and Other
Product Types Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 51: Europe 15-Year Perspective for Colonoscopy Devices by
Product Type – Percentage Breakdown of Value Sales for
Visualization Systems, Colonoscopes and Other Product Types for
the Years 2012, 2020 & 2027
Table 52: Europe Current & Future Analysis for Colonoscopy
Devices by End-Use – Hospitals, Diagnostic Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 53: Europe Historic Review for Colonoscopy Devices by
End-Use – Hospitals, Diagnostic Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 54: Europe 15-Year Perspective for Colonoscopy Devices by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers and Other End-Uses for the Years 2012, 2020 &
2027
FRANCE
Table 55: France Current & Future Analysis for Colonoscopy
Devices by Product Type – Visualization Systems, Colonoscopes
and Other Product Types – Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 56: France Historic Review for Colonoscopy Devices by
Product Type – Visualization Systems, Colonoscopes and Other
Product Types Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 57: France 15-Year Perspective for Colonoscopy Devices by
Product Type – Percentage Breakdown of Value Sales for
Visualization Systems, Colonoscopes and Other Product Types for
the Years 2012, 2020 & 2027
Table 58: France Current & Future Analysis for Colonoscopy
Devices by End-Use – Hospitals, Diagnostic Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 59: France Historic Review for Colonoscopy Devices by
End-Use – Hospitals, Diagnostic Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 60: France 15-Year Perspective for Colonoscopy Devices by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers and Other End-Uses for the Years 2012, 2020 &
2027
GERMANY
Table 61: Germany Current & Future Analysis for Colonoscopy
Devices by Product Type – Visualization Systems, Colonoscopes
and Other Product Types – Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 62: Germany Historic Review for Colonoscopy Devices by
Product Type – Visualization Systems, Colonoscopes and Other
Product Types Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 63: Germany 15-Year Perspective for Colonoscopy Devices
by Product Type – Percentage Breakdown of Value Sales for
Visualization Systems, Colonoscopes and Other Product Types for
the Years 2012, 2020 & 2027
Table 64: Germany Current & Future Analysis for Colonoscopy
Devices by End-Use – Hospitals, Diagnostic Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 65: Germany Historic Review for Colonoscopy Devices by
End-Use – Hospitals, Diagnostic Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 66: Germany 15-Year Perspective for Colonoscopy Devices
by End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers and Other End-Uses for the Years 2012, 2020 &
2027
ITALY
Table 67: Italy Current & Future Analysis for Colonoscopy
Devices by Product Type – Visualization Systems, Colonoscopes
and Other Product Types – Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 68: Italy Historic Review for Colonoscopy Devices by
Product Type – Visualization Systems, Colonoscopes and Other
Product Types Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 69: Italy 15-Year Perspective for Colonoscopy Devices by
Product Type – Percentage Breakdown of Value Sales for
Visualization Systems, Colonoscopes and Other Product Types for
the Years 2012, 2020 & 2027
Table 70: Italy Current & Future Analysis for Colonoscopy
Devices by End-Use – Hospitals, Diagnostic Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 71: Italy Historic Review for Colonoscopy Devices by
End-Use – Hospitals, Diagnostic Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 72: Italy 15-Year Perspective for Colonoscopy Devices by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers and Other End-Uses for the Years 2012, 2020 &
2027
UNITED KINGDOM
Table 73: UK Current & Future Analysis for Colonoscopy Devices
by Product Type – Visualization Systems, Colonoscopes and Other
Product Types – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 74: UK Historic Review for Colonoscopy Devices by Product
Type – Visualization Systems, Colonoscopes and Other Product
Types Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 75: UK 15-Year Perspective for Colonoscopy Devices by
Product Type – Percentage Breakdown of Value Sales for
Visualization Systems, Colonoscopes and Other Product Types for
the Years 2012, 2020 & 2027
Table 76: UK Current & Future Analysis for Colonoscopy Devices
by End-Use – Hospitals, Diagnostic Centers and Other End-Uses –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 77: UK Historic Review for Colonoscopy Devices by End-Use –
Hospitals, Diagnostic Centers and Other End-Uses Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 78: UK 15-Year Perspective for Colonoscopy Devices by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers and Other End-Uses for the Years 2012, 2020 &
2027
SPAIN
Table 79: Spain Current & Future Analysis for Colonoscopy
Devices by Product Type – Visualization Systems, Colonoscopes
and Other Product Types – Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 80: Spain Historic Review for Colonoscopy Devices by
Product Type – Visualization Systems, Colonoscopes and Other
Product Types Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 81: Spain 15-Year Perspective for Colonoscopy Devices by
Product Type – Percentage Breakdown of Value Sales for
Visualization Systems, Colonoscopes and Other Product Types for
the Years 2012, 2020 & 2027
Table 82: Spain Current & Future Analysis for Colonoscopy
Devices by End-Use – Hospitals, Diagnostic Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 83: Spain Historic Review for Colonoscopy Devices by
End-Use – Hospitals, Diagnostic Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 84: Spain 15-Year Perspective for Colonoscopy Devices by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers and Other End-Uses for the Years 2012, 2020 &
2027
RUSSIA
Table 85: Russia Current & Future Analysis for Colonoscopy
Devices by Product Type – Visualization Systems, Colonoscopes
and Other Product Types – Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 86: Russia Historic Review for Colonoscopy Devices by
Product Type – Visualization Systems, Colonoscopes and Other
Product Types Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 87: Russia 15-Year Perspective for Colonoscopy Devices by
Product Type – Percentage Breakdown of Value Sales for
Visualization Systems, Colonoscopes and Other Product Types for
the Years 2012, 2020 & 2027
Table 88: Russia Current & Future Analysis for Colonoscopy
Devices by End-Use – Hospitals, Diagnostic Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 89: Russia Historic Review for Colonoscopy Devices by
End-Use – Hospitals, Diagnostic Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 90: Russia 15-Year Perspective for Colonoscopy Devices by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers and Other End-Uses for the Years 2012, 2020 &
2027
REST OF EUROPE
Table 91: Rest of Europe Current & Future Analysis for
Colonoscopy Devices by Product Type – Visualization Systems,
Colonoscopes and Other Product Types – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 92: Rest of Europe Historic Review for Colonoscopy
Devices by Product Type – Visualization Systems, Colonoscopes
and Other Product Types Markets – Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 93: Rest of Europe 15-Year Perspective for Colonoscopy
Devices by Product Type – Percentage Breakdown of Value Sales
for Visualization Systems, Colonoscopes and Other Product Types
for the Years 2012, 2020 & 2027
Table 94: Rest of Europe Current & Future Analysis for
Colonoscopy Devices by End-Use – Hospitals, Diagnostic Centers
and Other End-Uses – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 95: Rest of Europe Historic Review for Colonoscopy
Devices by End-Use – Hospitals, Diagnostic Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 96: Rest of Europe 15-Year Perspective for Colonoscopy
Devices by End-Use – Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Centers and Other End-Uses for the Years
2012, 2020 & 2027
ASIA-PACIFIC
An Insight into Asia-Pacific Market for Colonoscopy Devices
Cancer Incidence in Asia: Number of New Cancer Cases
(in Thousands) for 2019
Table 97: Asia-Pacific Current & Future Analysis for
Colonoscopy Devices by Geographic Region – Australia, India,
South Korea and Rest of Asia-Pacific Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 98: Asia-Pacific Historic Review for Colonoscopy Devices
by Geographic Region – Australia, India, South Korea and Rest
of Asia-Pacific Markets – Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 99: Asia-Pacific 15-Year Perspective for Colonoscopy
Devices by Geographic Region – Percentage Breakdown of Value
Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027
Table 100: Asia-Pacific Current & Future Analysis for
Colonoscopy Devices by Product Type – Visualization Systems,
Colonoscopes and Other Product Types – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 101: Asia-Pacific Historic Review for Colonoscopy Devices
by Product Type – Visualization Systems, Colonoscopes and Other
Product Types Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 102: Asia-Pacific 15-Year Perspective for Colonoscopy
Devices by Product Type – Percentage Breakdown of Value Sales
for Visualization Systems, Colonoscopes and Other Product Types
for the Years 2012, 2020 & 2027
Table 103: Asia-Pacific Current & Future Analysis for
Colonoscopy Devices by End-Use – Hospitals, Diagnostic Centers
and Other End-Uses – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 104: Asia-Pacific Historic Review for Colonoscopy Devices
by End-Use – Hospitals, Diagnostic Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 105: Asia-Pacific 15-Year Perspective for Colonoscopy
Devices by End-Use – Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Centers and Other End-Uses for the Years
2012, 2020 & 2027
AUSTRALIA
Table 106: Australia Current & Future Analysis for Colonoscopy
Devices by Product Type – Visualization Systems, Colonoscopes
and Other Product Types – Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 107: Australia Historic Review for Colonoscopy Devices by
Product Type – Visualization Systems, Colonoscopes and Other
Product Types Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 108: Australia 15-Year Perspective for Colonoscopy
Devices by Product Type – Percentage Breakdown of Value Sales
for Visualization Systems, Colonoscopes and Other Product Types
for the Years 2012, 2020 & 2027
Table 109: Australia Current & Future Analysis for Colonoscopy
Devices by End-Use – Hospitals, Diagnostic Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 110: Australia Historic Review for Colonoscopy Devices by
End-Use – Hospitals, Diagnostic Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 111: Australia 15-Year Perspective for Colonoscopy
Devices by End-Use – Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Centers and Other End-Uses for the Years
2012, 2020 & 2027
INDIA
Table 112: India Current & Future Analysis for Colonoscopy
Devices by Product Type – Visualization Systems, Colonoscopes
and Other Product Types – Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 113: India Historic Review for Colonoscopy Devices by
Product Type – Visualization Systems, Colonoscopes and Other
Product Types Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 114: India 15-Year Perspective for Colonoscopy Devices by
Product Type – Percentage Breakdown of Value Sales for
Visualization Systems, Colonoscopes and Other Product Types for
the Years 2012, 2020 & 2027
Table 115: India Current & Future Analysis for Colonoscopy
Devices by End-Use – Hospitals, Diagnostic Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 116: India Historic Review for Colonoscopy Devices by
End-Use – Hospitals, Diagnostic Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 117: India 15-Year Perspective for Colonoscopy Devices by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers and Other End-Uses for the Years 2012, 2020 &
2027
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05896566/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Established market leader in stroke AI imaging receives its first FDA clearance in the lung imaging space.With this expanded foundation of AI-driven healthcare solutions, the Oxford-based company remains committed to driving innovation and delivering impactful advancements in imaging biomarkers.OXFORD, England, and CHICAGO, May 17, 2024 /PRNewswire/ — Brainomix, a pioneer in artificial intelligence (AI) imaging solutions to enable precision medicine, is proud to announce the FDA clearance of its latest product, Brainomix 360 e-Lung. Brainomix’s entry into the lung imaging space follows a series of successful clearances and widespread clinical adoption of its Brainomix 360 Stroke platform in both the US and Europe.
The clearance of e-Lung marks a significant milestone in Brainomix’s journey to expand its footprint in medical imaging beyond stroke-related applications and represents a notable step forward in the quest for advanced lung imaging solutions. The company, with its rich academic heritage and record of scientific excellence, will expand its research collaborations in the pulmonology space to yield new insights to inform future iterations of e-Lung and chart a path towards continual improvements for the lung imaging technology.
Dr Deji Adegunsoye, Assistant Professor of Medicine and Scientific Director of the Interstitial Lung Disease Program at University of Chicago Medicine, said: “This is an exciting step for Brainomix, who have a demonstrated track record of developing novel AI-based solutions in stroke and are now applying that expertise to develop innovative tools in the lung space. The preliminary data for e-Lung is impressive and would indicate that we have a promising tool that could help to expedite healthcare delivery and improve clinically meaningful outcomes for patients with lung disease.”
Brainomix recently announced the publication of a new study1 in the prestigious peer-reviewed journal American Journal of Respiratory and Critical Care Medicine (AJRCCM), resulting from a research collaboration with AstraZeneca. The results showed that Brainomix’s proprietary lung imaging biomarkers, which include the weighted reticulovascular score (WRVS), stratified patients at risk of Idiopathic Pulmonary Fibrosis (IPF) progression, outperforming standard measures.
Dr Michalis Papadakis, CEO and Co-Founder of Brainomix, said: “We are harnessing our expertise in AI-powered imaging to develop novel biomarkers in other disease indications where AI can support imaging-based diagnostic and treatment decisions.
“This e-Lung FDA clearance reflects our focus on developing innovative solutions that empower healthcare professionals with cutting-edge tools for sophisticated disease evaluation, enhancing access to treatments that can ultimately work to improve patient outcomes.”
Brainomix will be presenting its latest e-Lung data at the American Thoracic Society (ATS) annual conference in San Diego May 17th – 22nd, including results from research collaborations with Heidelberg University and with Seattle-based Avalyn Pharma.
Am. J. Respir. Crit. Care Med.: 2024 Feb 16 – e-Lung CT Biomarker Stratifies Patients at Risk of IPF Progression in a 52-Week Clinical Trialhttps://www.atsjournals.org/doi/abs/10.1164/rccm.202312-2274LEAbout Brainomix
Brainomix specializes in the creation of AI-powered software solutions to enable precision medicine for better treatment decisions in stroke and lung fibrosis. With origins as a spin-out from the University of Oxford, Brainomix is an expanding commercial-stage company with offices in the UK, Ireland and the USA, and operations in more than 30 countries. A private company, backed by leading healthtech investors, Brainomix has innovated award-winning imaging biomarkers and software solutions that have been clinically adopted in hundreds of hospitals worldwide. Its first product, the Brainomix 360 stroke platform, provides clinicians with the most comprehensive stroke imaging solution, driving increased treatment rates and improving functional independence for patients.
To learn more about Brainomix and its technology visit www.brainomix.com, and follow us on Twitter, LinkedIn and Facebook.
Contacts
Jeff Wyrtzen, Chief Marketing & Business Development [email protected] +44 (0)7927 164210T +44 (0)1865 582730
Media enquiries
Charles ConsultantsSue [email protected] M +44 (0)7968 726585
Logo – https://mma.prnewswire.com/media/1989193/3856380/Brainomix_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/brainomix-achieves-breakthrough-with-fda-clearance-of-e-lung-ai-software-302144836.html
Artificial Intelligence
CUBE acquires global regulatory intelligence businesses from Thomson Reuters
LONDON, May 17, 2024 /PRNewswire/ — CUBE, a global leader in Automated Regulatory Intelligence (ARI) and Regulatory Change Management (RCM), announces today its acquisition of the Thomson Reuters Regulatory Intelligence and Oden products and businesses.
The acquisition of these global businesses represents a major step forward in CUBE’s growth plans. It will deliver significant scale across many of the world’s leading and systemically important financial institutions. CUBE’s existing global customer base will be expanded to total approximately 1,000 customers in banking, insurance, asset and investment management, payments and adjacent regulated industries.
CUBE’s global employees will expand to 600, of which close to 250 are highly qualified regulatory subject matter experts, legal and compliance professionals.
Ben Richmond, founder and CEO of CUBE said: “Thomson Reuters is known to be the biggest and best in the industry for providing regulatory expert analysis and subject matter expertise, alongside world-leading journalism and news. The combination of CUBE’s purpose-built AI, with the years of content curated by Thomson Reuters Regulatory Intelligence and Oden expert analysts, will accelerate innovation. Together, we will deliver regulatory transformation capabilities for our global customers that could only have been imagined before.”
Richmond continues: “This combination will provide tremendous scale and depth across CUBE’s regulatory content and technology. It is a significant step toward creating an industry-defining regulatory compliance and risk platform that will benefit all customers and elevate the industry as a whole.”
Through this acquisition, CUBE will provide an expanded and comprehensive selection of specialized regulatory intelligence and regulatory change services, committed to excellence, quality, and highly contextualised and meaningful regulatory content for customers. By combining cutting-edge technology and subject matter expertise at scale CUBE will set a new bar for the industry in regulatory automation and content.
Chris Maguire, General Manager, Risk and Fraud, Corporates, Thomson Reuters said: “It was clear to us that CUBE had established itself as a leading regulatory intelligence provider for global enterprise clients in the financial services and insurance sectors. We wanted to ensure our customers and employees could work with an organisation that would continue to innovate and significantly invest in solutions like Thomson Reuters Regulatory Intelligence and Oden. We are working tirelessly to ensure a seamless and value-enhancing transition for customers and employees, and we are looking forward to working with the CUBE team during this transition.”
Christopher Fielding, Hg, said: “We’re delighted to further extend our market reach, bringing in two high quality and complementary global businesses to the CUBE platform.”
Thomas Martin, Hg, added: “We see these acquisitions as enabling further innovation in the regulatory intelligence and change management sector, leading to strengthened demand for these quality solutions across the globe.”
The terms of the transaction will not be disclosed.
About CUBE
CUBE provides a highly comprehensive and robust source of classified, and meaningful AI-driven regulatory data to power its Automated Regulatory Intelligence (ARI) and Regulatory Change Management (RCM) solutions. CUBE’s purpose-built regulatory technology including its AI engine (RegBrain) and software platform (RegPlatform) tracks, analyses, and monitors laws, rules, and regulations in every country and in every published language to create an always up-to-date regulatory footprint that transforms visibility and compliance capability for customers across the globe.
With operations across Europe, North America, Canada, Asia, and Australia, CUBE serves a diverse and global base of customers and partners including the largest financial institutions in the world who leverage CUBE’s platform to streamline their complex regulatory intelligence and change management processes.
Following the strategic partnership with Hg in March 2024, CUBE announced the acquisition of US-based Reg-Room in May 2024.
About Hg
Hg supports the building of sector-leading enterprises that supply businesses with critical software applications or workflow services, delivering a more automated workplace for their customers.
This industry is characterised by digitisation trends that are in early stages of adoption and are set to transform the workplace for professionals over decades to come. Hg’s support combines deep end-market knowledge with world class operational resources, together providing compelling support to entrepreneurial leaders looking to scale their business – businesses that are well invested, enduring and serve their customers well.
With a vast European network and strong presence across North America, Hg’s 400 employees and around $70 billion in funds under management support a portfolio of around 50 businesses, worth over $140 billion aggregate enterprise value, with over 110,000 employees, consistently growing revenues at more than 20%.
About Regulatory Intelligence
Regulatory Intelligence is a proactive, connected, and comprehensive solution that tracks and analyses regulatory changes within ~2,000 regulatory bodies and rulebooks for more than 20 countries. It enables banking, financial services, and insurance (BFSI) sectors to manage exposure to operational, regulatory, and compliance risk.
About Oden
Oden State Rules and Regulations (SR&R), Oden Policy Terminator/Sentry PT, and OdenTrack provide repositories and automated solutions for complying with state rules and regulations on the provisioning of Personal and Business Insurance in the US.
View original content:https://www.prnewswire.co.uk/news-releases/cube-acquires-global-regulatory-intelligence-businesses-from-thomson-reuters-302147604.html
Artificial Intelligence
Cayman Enterprise City Publishes Socio-Economic Impact Assessment by Economist and Leading Advisor on the Caribbean, Marla Dukharan
The Impact of Cayman Enterprise City’s Socio-Economic Development Project Nears USD $1 Billion
GRAND CAYMAN, Cayman Islands, May 16, 2024 /PRNewswire/ — Cayman Enterprise City (CEC) has released a Socio-Economic Impact Assessment by Marla Dukharan. The report illustrates that CEC is increasing its impact by supporting higher earnings for Caymanians and is driving a shift towards a knowledge-based economy by focusing on high productivity sectors. The release by Dukharan reads, “Caymanian resourcefulness and private sector-led innovation have been the driving force behind the islands’ outstanding socio-economic success. Cayman Enterprise City underpins the next generation of Cayman innovation and dynamism.”
With an economic impact of USD $130 million in 2023, contributing just under USD $1 billion to the local economic activity in 12 years since inception, “CEC is helping the nation to diversify economically, in terms of sectors and jobs, ensuring locals have economic and employment opportunities that match the nation’s progress,” the report reads.
The CEC socio-economic development project is now home to 352 Special Economic Zones Companies (SEZCos), many of which are globally recognised institutions led by top executives and industry experts. “CEC member companies are providing high-value employment with salaries exceeding those typically found outside of the special economic zone,” said Charlie Kirkconnell, Chief Executive Officer at CEC. “The CEC community is fully invested in Cayman and the report illustrates that the CEC socio-economic development project is making a very significant impact on Cayman’s economy and community.”
“As CEC continues to grow, it continues to create significant employment and entrepreneurial opportunities for Caymanians and we encourage anyone that might be interested in finding out how they might get involved, whether as a member of the community and/or as a volunteer in our Enterprise Cayman non-profit organisation (NPO).”
77% of Caymanian-held jobs at CEC member companies, are in sectors with high social returns and increasing global demand. “By putting skills first and prioritizing learning, CEC is enabling new industries to take root,” the release by Dukharan reads.
CEC, through its Enterprise Cayman NPO, is a first-mover in private sector-facilitated education and training in the Caribbean, making it a leading force to boost youth participation in the economy. By offering training in specialised skills, Enterprise Cayman is helping to close the gap in higher education and earnings for Caymanians. “Through Enterprise Cayman we’ve set out to strategically support meaningful employment and entrepreneurial opportunities for Caymanians, by providing internship and mentorship opportunities, by hosting skill-building and career focused training, and by providing invaluable networking and community engagement opportunities,” said Kirkconnell.
In 2023 individuals took advantage of 4,226 opportunities to participate in education, training, and career development events and, since launching entrepreneurial programming in 2021, Enterprise Cayman has worked with 41 new Cayman-born business ventures. “We’re helping to develop a local talent pool that meets the demand of Cayman’s growing digital innovation and technology sectors while, in parallel, offering exciting opportunities for individuals to launch new business ventures within an innovative business environment,” said Kirkconnell.
With CEC’s new campus and state-of-the-art facilities, Signal House, the project “holds the promise of deep, continued economic impact,” the report concludes.
To access CEC’s economic impact assessments and Enterprise Cayman’s annual reports please visit https://www.enterprisecayman.ky/reports. For more information on how to get involved and for upcoming programmes and events visit www.enterprisecayman.ky.
Website: www.caymanenterprisecity.com LinkedIn: @CaymanEnterpriseCityTwitter: @CEC_CaymanInstagram: @CaymanEnterpriseCityFacebook: @CaymanEnterpriseCityYouTube: @ceccayman
About Cayman Enterprise City
Cayman Enterprise City (CEC) is an award-winning development project which consists of three special economic zones (SEZs) focused on attracting knowledge-based and specialised-services businesses to set up a genuine physical presence in the Cayman Islands. The zones included within CEC are Cayman Tech City, Cayman Commodities & Derivatives Centre, and Cayman Maritime & Aviation City. With a dedicated Government Authority, licensing fee concessions and guaranteed fast-track processes, CEC enables international companies to quickly and efficiently establish a Cayman Islands office, which in turn enables them to generate active business income within a tax neutral environment.
About Enterprise Cayman
Enterprise Cayman is a non-profit organisation (NPO) powered by Cayman Enterprise City in partnership with Cayman Islands’ special economic zone companies (SEZCos). The organisation, which applies the Theory of Change (TOC) methodology, provides Caymanians and residents with access to high-quality learning experiences and opportunities to develop and launch new business ventures, to pursue careers within the technology and innovation sectors, and to join a dynamic network of industry professionals. Let’s grow the next generation of Caymanian innovators and entrepreneurs with Enterprise Cayman!
Logo: https://mma.prnewswire.com/media/1317764/2860789/Cayman_Enterprise_City_Logo.jpg
FOR MORE INFORMATION:Contact: Kaitlyn Elphinstone Email: [email protected]
View original content:https://www.prnewswire.co.uk/news-releases/cayman-enterprise-city-publishes-socio-economic-impact-assessment-by-economist-and-leading-advisor-on-the-caribbean-marla-dukharan-302148206.html
-
Artificial Intelligence7 days agoIdentity Threat Detection and Response (ITDR) Market worth $35.6 billion by 2029- Exclusive Report by MarketsandMarkets™
-
Artificial Intelligence7 days agoatNorth Shortlisted for Datacloud Global Awards, The Energy Awards and The Women in Green Business Awards
-
Artificial Intelligence6 days agoWIO Taps Gracenote to Revolutionize Television Broadcast Reporting
-
Artificial Intelligence7 days agoProofID wins Judges’ Award for Global Ambition at the 2024 Northern Tech Awards
-
Artificial Intelligence7 days agoIDTechEx Explores Printed Electronics in Electrified and Autonomous Mobility
-
Uncategorized4 days agoCrossover Markets Becomes First Crypto ECN to Integrate with Talos
-
Uncategorized4 days ago
Precisely Showcases Critical Role of Trusted Data in AI at the Gartner® Data & Analytics Summit in London
-
Uncategorized3 days ago
Artificial intelligence tool detects sex-related differences in brain structure
